Showing results (191-200 of 255) with videos related to

Sort By:
Pageof 26
The American Journal of Medicine|March 1, 1997
Vascular abnormalities associated with long-term cigarette smoking identified by arterial waveform analysisG E McVeigh, D J Morgan, S M Finkelstein, et al.
Journal of the American College of Cardiology|March 1, 1994
Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunctionK M McDonald, M Yoshiyama, G S Francis, et al.
American Heart Journal|February 1, 1994
Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failureT P Connelly, G S Francis, K J Williams, et al.
Circulation|June 1, 1993
Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies GroupG S Francis, J N Cohn, G Johnson, et al.
Journal of the American College of Cardiology|December 1, 1983
Impaired response of plasma vasopressin to orthostatic stress in patients with congestive heart failureS R Goldsmith, G S Francis, T B Levine, et al.
Chest|January 1, 1981
The effectiveness of cardiology consultation. Concordance with diagnostic and drug recommendationsT B Mackenzie, M K Popkin, A L Callies, et al.
Annals of Internal Medicine|September 1, 1984
The neurohumoral axis in congestive heart failureG S Francis, S R Goldsmith, T B Levine, et al.
Circulation|June 1, 1993
Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. V-HeFT VA Cooperative Studies GroupM Wong, G Johnson, R Shabetai, et al.
The American Journal of Cardiology|May 15, 1996
Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigatorsW E Boden, S Ziesche, P E Carson, et al.
Circulation|June 1, 1993
Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies GroupH S Loeb, G Johnson, A Henrick, et al.
Pageof 26